In the matter of Pan Pharmaceuticals Limited [2003] FCA 598
Given the detailed and largely uncontested evidence of the complexity and unique circumstances of the VA companies' administration, including the scale of the product recall, the volume and size of potential creditor claims, and the ongoing issues with the TGA and manufacturing licence, a 75-day extension is required to provide creditors with the information necessary to make an informed decision as envisaged by the Act.
- Parties
- Applicants: Anthony Gregory McGrath and Christopher John Honey (as joint administrators of Pan Pharmaceuticals Limited (Administrators Appointed) and of subsidiaries); Subject Companies: Pan Pharmaceuticals Limited (Administrators Appointed) (ACN 091 032 914) and subsidiaries as listed; Objector/director/contributory: James Selim
- Jurisdiction
- Australia
- Judgment Date
- 06 June 2003
- Procedural Posture
- Corporations – Voluntary Administration / Application for Extension of Convening Period for Second Meeting of Creditors Under S 439 a
- Outcome
- Application granted
- Legal Topics
- Voluntary Administration, Extension of Convening Period, Meetings of Creditors, Powers of Administrators
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Anthony Gregory McGrath and Christopher John Honey (as joint administrators of Pan Pharmaceuticals Limited (Administrators Appointed) and of subsidiaries)
Applicants
Pan Pharmaceuticals Limited (Administrators Appointed) (ACN 091 032 914) and subsidiaries as listed
Subject Companies
James Selim
Objector/director/contributory
Procedural Posture
Corporations – Voluntary Administration / Application for Extension of Convening Period for Second Meeting of Creditors Under S 439 a
Legal Issues
- 1 Whether to extend the convening period for the second meeting of creditors pursuant to s 439A(6) of the Corporations Act 2001 (Cth)
- 2 Whether it is preferable for the administrators to seek additional time now or for creditors to make that decision at a meeting adjourned under the Act
Ratio Decidendi
Given the detailed and largely uncontested evidence of the complexity and unique circumstances of the VA companies' administration, including the scale of the product recall, the volume and size of potential creditor claims, and the ongoing issues with the TGA and manufacturing licence, a 75-day extension is required to provide creditors with the information necessary to make an informed decision as envisaged by the Act.
Court Disposition
Application granted
Orders
- Extension of the convening period for the meetings of creditors under s 439A of the Corporations Act 2001 (Cth) with respect to Pan Pharmaceuticals Limited (Administrators Appointed) ACN 091 032 914; Pan Pharmaceuticals Export Pty Limited (Administrators Appointed) ACN 100 897 514; Pan Laboratories (Australia) Pty...
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment